Distinct NKT cell subsets are induced by different Chlamydia species leading to differential adaptive immunity and host resistance to the infections

Journal of Immunology

Volumn 178, Issue 2, 2007, Pages 1048-1058

  Joyee, Antony George ^a   Qiu, Hongyu ^a   Wang, Shuhe ^a   Fan, Yijun ^a   Bilenki, Laura ^a   Yang, Xi ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CHLAMYDIA; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOST RESISTANCE; IMMUNE RESPONSE; INFECTION RESISTANCE; INFECTION SENSITIVITY; KNOCKOUT MOUSE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 33846235965     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.2.1048     Document Type: Article

References (46)

1. Godfrey, D. I., J. McCluskey, and J. Rossjohn. 2005. CD1d antigen presentation: treats for NKT cells. Nat. Immunol. 6: 754-756.
2. Godfrey, D. I., K. J. Hammond, L. D. Poulton, M. J. Smyth, and A. G. Baxter. 2000. NKT cells: facts, functions and fallacies. Immunol. Today 21: 573-583.
3. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145-173.
4. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17: 138-146.
5. Smyth, M. J., K. Y. Thia, S. E. Street, E. Cretney, J. A. Trapani, M. Taniguchi, T. Kawano, S. B. Pelikan, N. Y. Crowe, and D. I. Godfrey. 2000. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191: 661-668.
6. Yang, Y., M. Bao, and J. W. Yoon. 2001. Intrinsic defects in the T-cell lineage results in natural killer T-cell deficiency and the development of diabetes in the nonobese diabetic mouse. Diabetes 50: 2691-2699.
7. Crowe, N. Y., J. M. Coquet, S. P. Berzins, K. Kyparissoudis, R. Keating, D. G. Pellicci, Y. Hayakawa, D. I. Godfrey, and M. J. Smyth. 2005. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202: 1279-1288.
8. van Dommelen, S. L., H. A. Tabarias, M. J. Smyth, and M. A. Degli-Esposti. 2003. Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells. J. Virol. 77: 1877-1884.
9. Chackerian, A., J. Alt, V. Perera, and S. M. Behar. 2002. Activation of NKT cells protects mice from tuberculosis. Infect. Immun. 70: 6302-6309.
10. Gonzalez-Aseguinolaza, G., C. de Oliveira, M. Tomaska, S. Hong, O. Bruna-Romero, T. Nakayama, M. Taniguchi, A. Bendelac, L. Van Kaer, Y. Koezuka, and M. Tsuji. 2000. α-Galactosylceramide-activated Vα 14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA 97: 8461-8466.
11. Duthie, M. S., and S. J. Kahn. 2002. Treatment with α- galactosylceramide before Trypanosoma cruzi infection provides protection or induces failure to thrive. J. Immunol. 168: 5778-5785.
12. Nieuwenhuis, E. E., T. Matsumoto, M. Exley, R. A. Schleipman, J. Glickman, D. T. Bailey, N. Corazza, S. P. Colgan, A. B. Onderdonk, and R. S. Blumberg. 2002. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 8: 588-593.
13. + natural killer T cells by α-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect. Immun. 69: 213-220.
14. + vαl4 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int. Immunol. 12: 1267-1274.
15. Grubor-Bauk, B., A. Simmons, G. Mayrhofer, and P. G. Speck. 2003. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant Vαl14-Jα 281 TCR. J. Immunol. 170: 1430-1434.
16. + T cells and amplification of antiviral immune responses to respiratory syncytial virus. J. Virol. 16: 4294-4303.
17. Brossay, L., M. Chioda, N. Burdin, Y. Koezuka, G. Casorati, P. Dellabona, and M. Kronenberg. 1998. CD1d-mediated recognition of an α- galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188: 1521-1528.
18. Nieda, M., A. Nicol, Y. Koezuka, A. Kikuchi, T. Takahashi, H. Nakamura, H. Furukawa, T. Yabe, Y. Ishikawa, K. Tadokoro, and T. Juji. 1999. Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner. Hum. Immunol. 60: 10-19.
19. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4: 231-237.
20. Gumperz, J. E., S. Miyake, T. Yamamura, and M. B. Brenner. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195: 625-636.
21. Lee, P. T., K. Benlagha, L. Teyton, and A. Bendelac. 2002. Distinct functional lineages of human Vα24 natural killer T cells. J. Exp. Med. 195: 637-641.
22. Kuo, C. C., L. A. Jackson, L. A. Campbell, and J. T. Grayston. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8: 451-461.
23. Johnston, S. C., L. M. Messina, W. S. Browner, M. T. Lawton, C. Morris, and D. Dean. 2001. C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis. Stroke 32: 2748-2752.
24. Balin, B. J., H. C. Gerard, E. J. Arking, D. M. Appell, P. J. Branigan, J. T. Abrams, J. A. Whittum-Hudson, and A. P. Hudson. 1998. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med. Microbiol. Immunol. 187: 23-42.
25. Grimaldi, L. M., A. Pincherle, F. Martinelli-Boneschi, M. Filippi, F. Patti, A. Reggio, D. Franciotta, L. Allegra, G. Comi, and F. Blasi. 2003. An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients. Mult. Scler. 9: 467-471.
26. Halme, S., J. Latvala, R. Karttunen, I. Palatsi, P. Saikku, and H. M. Surcel. 2000. Cell-mediated immune response during primary Chlamydia pneumoniae infection. Infect. Immun. 68: 7156-7158.
27. Pentilla, J. M., M. Anttila, M. Puolakkainen, A. Laurila, K. Varkila, M. Sarvas, P. H. Makela, and N. Rautonen. 1998. Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection. Infect. Immun. 66: 5113-5118.
28. Rottenberg, M. E., A. C. Gigliotti Rothfuchs, D. Gigliotti, C. Svanholm, L. Bandholtz, and H. Wigzell. 1999. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J. Immunol. 162: 2829-2836.
29. + cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice. Immunology 97: 490-496.
30. Yang, X., K. T. HayGlass, and R. C. Brunham. 1996. Genetically determined differences in IL-10 and IFN-γ responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J. Immunol. 156: 4338-4344.
31. Wang, S., Y. Fan, R. C. Brunham, and X. Yang. 1999. IFN-γ knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection. Eur. J. Immunol. 29:3782-3792.
32. Yang, X., K. T. Hayglass, and R. C. Brunham. 1998. Different roles are played by αβ and γδ T cells in acquired immunity to Chlamydia trachomatis pulmonary infection. Immunology 94: 469-475.
33. Rottenberg, M. E., A. Gigliotti Rothfuchs, D. Gigliotti, M. Ceausu, C. Une, V. Levitsky, and H. Wigzell. 2000. Regulation and role of IFN-γ in the innate resistance to infection with Chlamydia pneumoniae. J. Immunol. 164: 4812-4818.
34. Geng, Y., K. Berencsi, Z. Gyulai, T. Valyi-Nagy, E. Gonczol, and G. Trinchieri. 2000. Roles of interleukin-12 and γ interferon in murine Chlamydia pneumoniae infection. Infect. Immun. 68: 2245-2253.
35. Bilenki, L., S. Wang, J. Yang, Y. Fan, A. G. Joyee, and X. Yang. 2005. NK T cell activation promotes Chlamydia trachomatis infection in vivo. J. Immunol. 175: 3197-3206.
36. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626.
37. Mukhopadhyay, S., A. P. Clark, E. D. Sullivan, R. D. Miller, and J. T. Summersgill. 2004. Detailed protocol for purification of Chlamydia pneumoniae elementary bodies. J. Clin. Microbiol. 42: 3288-3290.
38. Netea, M. G., B. J. Kullberg, L. E. Jacobs, T. J. Verver-Jansen, J. van der Ven-Jongekrijg, J. M. Galama, A. F. Stalenhoef, C. A. Dinarello, and J. W. Van der Meer. 2004. Chlamydia pneumoniae stimulates IFN-γ synthesis through MyD88-dependent, TLR2- and TLR4-independent induction of IL-18 release. J. Immunol. 173: 1477-1482.
39. + Tc1 responses that inhibit intracellular growth of this vacuolar pathogen. J. Immunol. 169: 2524-2535.
40. + cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-γ. J. Immunol. 172: 2407-2415.
41. + T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniae. J. Immunol. 174: 5729-5739.
42. Hansen, D. S., M. A. Siomos, L. Buckingham, A. A. Scalzo, and L. Schofield. 2003. Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. Immunity 18: 391-402.
43. + T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones. Infect. Immun. 62: 5195-5197.
44. Magee, D. M., D. M. Williams, J. G. Smith, C. A. Bleicker, B. G. Grubbs, J. Schachter, and R. G. Rank. 1995. Role of CD8 T cells in primary Chlamydia infection. Infect. Immun. 63: 516-521.
45. Williams, D. M., B. G. Grubbs, E. Pack, K. Kelly, and R. G. Rank. 1997. Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis. Infect. Immun. 65: 2876-2882.
46. Cornish, A. L., R. Keating, K. Kyparissoudis, M. J. Smyth, F. R. Carbone, and D. I. Godfrey. 2006. NKT cells are not critical for HSV-1 disease resolution. Immunol. Cell Biol. 84: 13-19.